BIOMERICA INC Deferred State and Local Income Tax Expense (Benefit)
BIOMERICA INC (BMRA) reported Deferred State and Local Income Tax Expense (Benefit) of $123.59 thousand for the 12-month period ending 2016-05-31, per its 10-K filed 2017-08-29.
Discontinued › Expense Statement › Income Tax
us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit · last filed 2017-08-29
- BIOMERICA INC deferred state and local income tax expense (benefit) for fiscal 2016 was $123.59K.
- BIOMERICA INC deferred state and local income tax expense (benefit) for fiscal 2015 was -$30.58K.
- BIOMERICA INC deferred state and local income tax expense (benefit) for fiscal 2014 was -$43.00K, a 551.63% decline from fiscal 2013.
- BIOMERICA INC deferred state and local income tax expense (benefit) for fiscal 2013 was $9.52K, a 495.06% increase from fiscal 2012.
| Period end | Deferred State and Local Income Tax Expense (Benefit) 12 month |
|---|---|
| 2016-05-31 | $123.59K 10-K · filed 2017-08-29 |
| 2015-05-31 | -$30.58K 10-K · filed 2016-08-29 |
| 2014-05-31 | -$43.00K 10-K · filed 2015-08-31 |
| 2013-05-31 | $9.52K 10-K · filed 2014-08-29 |
| 2012-05-31 | $1.60K 10-K · filed 2013-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |